In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia

Bone Marrow Transplantation

Volumn 22, Issue 12, 1998, Pages 1185-1190

  Lim, S H ^a,b   Coleman, S ^a   Bailey Wood, R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CML; Costimulatory molecules; Immunogenicity

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MARKER; T6 ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032435580     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701511     Document Type: Article

References (11)

1. Lim SH, Coleman S. CML as an immunological target. Am J Hematol 1997; 54: 61-67.
2. Coleman S, Perera P, Fisher J et al. Abnormal TCR V repertoire in patients with chronic myeloid leukaemia. Br J Haematol 1995; 90, 358-361.
3. Coleman S, Fisher J, Hoy T et al. Autologous MHC-dependent leukaemia-reactive T lymphocytes in a patient with chronic myeloid leukaemia. Leukemia 1996; 10: 483-487.
4. Lim SH, Coleman S, Bull A et al. Cyclosporin-A/alpha interferon-induced autologous graft-versus-host disease following peripheral blood stem cell transplant for chronic myeloid leukaemia: a clinico-pathological study. Bone Marrow Transplant 1997; 20: 83-85.
5. + T cells by B7-transfected melanoma cells. Science 1993; 259: 368-370.
6. Huang AY, Golumbek P, Ahmadzadeh M et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994; 264: 961-965.
7. Guo Y, Wu M, Chen H et al. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science 1994; 263: 518-520.
8. Coleman S, Throp D, Fisher J et al. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia. Leukemia 1997; 11: 2055-2059.
9. Choudhury A, Gajewski JL, Liang JC et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 1997; 89: 1133-1142.
10. Smit WM, Rijnbeek M, van Bergen CAM et al. Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells. Hum Immunol 1997; 53: 216-223.
11. Wen YJ, Ling M, Bailey-Wood R, Lim SH. Id-pulsed dendritic cells prime immune system in multiple myeloma. Clin Cancer Res 1998; 4: 957-962.